Sasha E Stanton

8PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersTumour immunologyMolecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 04, 2026
Safety and immunogenicity of a tri-antigen vaccine targeting IGFBP-2, HER2, and IGF-IR in participants with non-metastatic breast cancer.

|Nov 27, 2025
Exploratory Analysis of the Impact of a Single Dose of Trastuzumab on the Immune Microenvironment in HER2-Positive Early-Stage Breast Cancer.

Nikita Bastin, Jessica Mezzanotte-Sharpe, Rebecca Alvarez

|Mar 28, 2025
SITC strategic vision: prevention, premalignant immunity, host and environmental factors.

Sasha E Stanton, Kristin G Anderson, Tullia C Bruno

|Nov 09, 2024
Magnitude of antigen-specific T-cell immunity the month after completing vaccination series predicts the development of long-term persistence of antitumor immune response.

John B Liao, James Y Dai, Jessica L Reichow

|Mar 22, 2024
Advances and challenges in cancer immunoprevention and immune interception.

Sasha E Stanton, Philip E Castle, Olivera J Finn

|Jan 20, 2022
Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report.

Altaf Mohammed, Roderick H Dashwood, Sally Dickinson

Pageof 2

Frequent Collaborators

3 joint publications

John B Liao

1 joint publications

Altaf Mohammed

1 joint publications

Roderick H Dashwood

1 joint publications

Sally Dickinson